These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4001740)

  • 21. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immune response in rubella infections.
    Buimovici-Klein E; Cooper LZ
    Rev Infect Dis; 1985; 7 Suppl 1():S123-8. PubMed ID: 2408312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rubella immunization. Persistence of antibody four years after a large-scale field trial.
    Herrmann KL; Halstead SB; Brandling-Bennett AD; Witte JJ; Wiebenga NH; Eddins DL
    JAMA; 1976 May; 235(20):2201-4. PubMed ID: 946844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Microtiter enzyme-linked immunosorbent assay for rubella antibodies in human sera--analysis by parallel line assay method].
    Morita M; Suzuki T; Suzuki Y; Hoshino H
    Kansenshogaku Zasshi; 1992 Aug; 66(8):1075-83. PubMed ID: 1402112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of an M antibody capture ELISA for rubella IgM.
    Bellamy K; Rousseau SA; Gardner PS
    J Virol Methods; 1986 Nov; 14(3-4):243-51. PubMed ID: 3539958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failed rubella immunization in adults: association with immunologic and virological abnormalities.
    Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M
    J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses to wild and vaccine rubella viruses after rubella vaccination.
    Cusi MG; Metelli R; Valensin PE
    Arch Virol; 1989; 106(1-2):63-72. PubMed ID: 2764728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of in vivo challenge to assess rubella immunity determined by haemagglutination inhibition and latex agglutination.
    Grangeot-Keros L; Badur S; Pons JC; Duthu S; Pillot J
    Res Virol; 1989; 140(5):437-42. PubMed ID: 2587849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
    Okafuji T; Okafuji T; Nakayama T
    Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands.
    Chu SY; Bernier RH; Stewart JA; Herrmann KL; Greenspan JR; Henderson AK; Liang AP
    JAMA; 1988 Jun; 259(21):3133-6. PubMed ID: 3367488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines to prevent rubella.
    André FE; Florent G; du Pan RM
    Lancet; 1980 Mar; 1(8169):657-8. PubMed ID: 6102664
    [No Abstract]   [Full Text] [Related]  

  • 39. Serologic response to revaccination with two rubella vaccines.
    Brandling-Bennett AD; Jackson RS; Halstead SB; Campbell CC; Herrmann KL; Modlin JF; Meyers JD; Witte JJ
    Am J Dis Child; 1976 Oct; 130(10):1081-4. PubMed ID: 973610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
    Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.